Prime Medicine, Inc.
General ticker "PRME" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $453.9M (TTM average)
Prime Medicine, Inc. follows the US Stock Market performance with the rate: 9.0%.
Estimated limits based on current volatility of 4.9%: low 2.75$, high 3.04$
Factors to consider:
- Total employees count: 175 as of 2022
- Price in estimated range
- Earnings for 3 months up through Q1 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.55$, 7.40$]
- 2026-12-31 to 2027-12-31 estimated range: [2.12$, 6.27$]
Financial Metrics affecting the PRME estimates:
- Positive: with PPE of -2.6 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: 19.24 < Shareholder equity ratio, % of 35.27 <= 42.59
Short-term PRME quotes
Long-term PRME plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $2.98MM | $4.63MM |
| Operating Expenses | $204.79MM | $205.45MM | $212.98MM |
| Operating Income | $-204.79MM | $-202.47MM | $-208.35MM |
| Non-Operating Income | $6.38MM | $6.58MM | $7.21MM |
| R&D Expense | $147.91MM | $155.29MM | $160.64MM |
| Income(Loss) | $-198.41MM | $-195.88MM | $-201.14MM |
| Taxes | $-0.28MM | $0.00MM | $0.00MM |
| Net Income(Loss)* | $-198.13MM | $-195.88MM | $-201.14MM |
| Stockholders Equity | $133.07MM | $153.15MM | $120.87MM |
| Assets | $193.85MM | $297.51MM | $342.73MM |
| Operating Cash Flow | $-165.41MM | $-122.86MM | $-162.56MM |
| Capital expenditure | $8.72MM | $7.29MM | $4.53MM |
| Investing Cash Flow | $18.71MM | $68.46MM | $-108.76MM |
| Financing Cash Flow | $0.66MM | $195.88MM | $151.51MM |
| Earnings Per Share** | $-2.18 | $-1.65 | $-1.35 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.